NO20092413L - Pyrazolanaloger - Google Patents

Pyrazolanaloger

Info

Publication number
NO20092413L
NO20092413L NO20092413A NO20092413A NO20092413L NO 20092413 L NO20092413 L NO 20092413L NO 20092413 A NO20092413 A NO 20092413A NO 20092413 A NO20092413 A NO 20092413A NO 20092413 L NO20092413 L NO 20092413L
Authority
NO
Norway
Prior art keywords
disorders
compounds
preparation
conditions
pyrazolanaloger
Prior art date
Application number
NO20092413A
Other languages
English (en)
Inventor
Todd Michael Maddux
Matthew J Graneto
Jaime L Masferrer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20092413L publication Critical patent/NO20092413L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen er relatert til forbindelsen av formel (I): eller et farmasøytisk akseptabelt salt og solvat derav, hvor R1 er F eller H og til fremgangsmåter for fremstillingen av, intermediater benyttet i prepareringen av, sammensetninger inneholdende anvendelsene av, slike forbindelser. Forbindelsene i henhold til den foreliggende oppfinnelsen er nyttige i tallrike sykdommer, lidelser og tilstander, spesielt allergiske og respiratoriske sykdommer, lidelser og tilstander.
NO20092413A 2006-11-27 2009-06-24 Pyrazolanaloger NO20092413L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86733706P 2006-11-27 2006-11-27
PCT/IB2007/003518 WO2008065493A1 (en) 2006-11-27 2007-11-14 Pyrazole analogs

Publications (1)

Publication Number Publication Date
NO20092413L true NO20092413L (no) 2009-07-20

Family

ID=39226772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092413A NO20092413L (no) 2006-11-27 2009-06-24 Pyrazolanaloger

Country Status (32)

Country Link
US (1) US7772269B2 (no)
EP (1) EP2097407A1 (no)
JP (1) JP4469924B2 (no)
KR (1) KR20090074264A (no)
CN (1) CN101541790A (no)
AP (1) AP2009004849A0 (no)
AR (1) AR063924A1 (no)
AU (1) AU2007327004A1 (no)
BR (1) BRPI0718672A2 (no)
CA (1) CA2667566C (no)
CL (1) CL2007003403A1 (no)
CO (1) CO6180447A2 (no)
CR (1) CR10745A (no)
CU (1) CU23801B7 (no)
DO (1) DOP2009000121A (no)
EA (1) EA016588B1 (no)
EC (1) ECSP099328A (no)
GE (1) GEP20125386B (no)
GT (1) GT200700104A (no)
HN (1) HN2007000505A (no)
IL (1) IL198412A0 (no)
MA (1) MA30924B1 (no)
MX (1) MX2009005526A (no)
NO (1) NO20092413L (no)
NZ (1) NZ576376A (no)
PE (1) PE20081299A1 (no)
RS (1) RS20090211A (no)
TN (1) TN2009000205A1 (no)
TW (1) TW200831495A (no)
UA (1) UA92833C2 (no)
UY (1) UY30743A1 (no)
WO (1) WO2008065493A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101918392A (zh) 2007-11-26 2010-12-15 辉瑞有限公司 作为5-lo抑制剂的吡唑衍生物
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden
WO2011137363A1 (en) * 2010-04-30 2011-11-03 Allergan, Inc. Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
TWI527809B (zh) * 2011-01-24 2016-04-01 百靈佳殷格翰國際股份有限公司 作為ｃｒｔｈ２拮抗劑之吡唑化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
PL176522B1 (pl) 1993-06-14 1999-06-30 Pfizer Nowe pochodne imidazolu
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JP3400392B2 (ja) * 1994-10-18 2003-04-28 ファイザー製薬株式会社 ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
DK0863905T3 (da) 1995-09-18 2001-01-02 Pfizer Imidazollipoxygenaseinhibitorer
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
JP2001100686A (ja) * 1999-09-28 2001-04-13 Hitachi Kokusai Electric Inc 表示データ取込方法及び比較検査装置
JP2001100682A (ja) * 1999-09-28 2001-04-13 Sanyo Electric Co Ltd サインシステム

Also Published As

Publication number Publication date
TN2009000205A1 (fr) 2010-10-18
UY30743A1 (es) 2008-07-03
CU20090083A7 (es) 2011-09-21
US20080125474A1 (en) 2008-05-29
UA92833C2 (en) 2010-12-10
WO2008065493A1 (en) 2008-06-05
CA2667566C (en) 2012-01-03
KR20090074264A (ko) 2009-07-06
CN101541790A (zh) 2009-09-23
MX2009005526A (es) 2009-06-05
TW200831495A (en) 2008-08-01
US7772269B2 (en) 2010-08-10
MA30924B1 (fr) 2009-11-02
CA2667566A1 (en) 2008-06-05
EA200970422A1 (ru) 2009-12-30
AR063924A1 (es) 2009-02-25
CR10745A (es) 2009-05-22
IL198412A0 (en) 2010-02-17
RS20090211A (sr) 2010-10-31
NZ576376A (en) 2011-02-25
JP4469924B2 (ja) 2010-06-02
EA016588B1 (ru) 2012-06-29
CL2007003403A1 (es) 2008-07-04
ECSP099328A (es) 2009-06-30
PE20081299A1 (es) 2008-09-17
HN2007000505A (es) 2010-06-09
AP2009004849A0 (en) 2009-06-30
EP2097407A1 (en) 2009-09-09
CU23801B7 (es) 2012-03-15
BRPI0718672A2 (pt) 2013-11-26
DOP2009000121A (es) 2009-06-15
GEP20125386B (en) 2012-01-25
JP2010511601A (ja) 2010-04-15
GT200700104A (es) 2011-04-13
AU2007327004A1 (en) 2008-06-05
CO6180447A2 (es) 2010-07-19

Similar Documents

Publication Publication Date Title
NO20084005L (no) Aminderivater
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
UA99524C2 (ru) Триазолопроизводные, полезные для лечения болезней
NO20091560L (no) Biaryleterureaforbindelser
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
WO2004080964A8 (en) Indole derivatives useful for the treatment of diseases
TW200833675A (en) Nicotinamide derivatives
TW200505865A (en) Compounds useful for the treatment of diseases
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
EA200601462A1 (ru) Соединения для лечения заболеваний
WO2008077810A3 (en) Spiro-piperidine derivatives
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
NO20075080L (no) Pyridylmetylsulfonderivater
MX2009005526A (es) Analogos de pirazol.
WO2005090287A3 (en) Phenylethanolamine derivatives as beta-2 agonists
MX2009005504A (es) Derivados de espiro piperidina como antagonistas del receptor via.
TW200730498A (en) Compounds
ATE317380T1 (de) Bernsteinsäurederivate
NO20064806L (no) Formamidderivater anvendelige som adenoceptor
NO20064805L (no) Sammensetninger for behandling av sykdommer
UA86615C2 (en) Formamide derivatives useful as adrenoceptor
NO20063875L (no) Forbindelser som anvendes for behandling av sykdommer
TH89765A (th) อนุพันธ์เอไมด์ที่ถูกแทนที่และวิธีการของการใช้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application